TransMedics Investors Face April 15 Class Action Deadline

A securities class action lawsuit has been initiated against TransMedics Group, Inc. (NASDAQ: TMDX) and several top executives for alleged violations of federal securities laws during the period from February 28, 2023, to January 10, 2025. Plaintiffs claim that TransMedics misled investors by engaging in kickbacks, fraudulent overbilling, and unsafe practices, while failing to disclose significant safety issues and regulatory risks. The lawsuit follows a February 21, 2024, letter from U.S. Representative Paul Gosar, which accused TransMedics of misconduct and led to a notable drop in the company's stock price. Additionally, a January 10, 2025, report from Scorpion Capital further alleged fraudulent activities, causing additional declines in the stock's value. Investors have until April 15, 2025, to apply for lead plaintiff status in the case, which is filed in the U.S. District Court for Massachusetts under the caption Jewik v. TransMedics Group, Inc. et al.